The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers

The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers

Dettagli Bibliografici
Autori principali:	Ilyas, M, Tomlinson, I, Rowan, A, Pignatelli, M, Bodmer, W
Natura:	Journal article
Pubblicazione:	1997

Documenti analoghi

Beta-catenin mutations in cell lines established from human colorectal cancers.
di: Ilyas, M, et al.
Pubblicazione: (1997)

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
di: Bicknell, D, et al.
Pubblicazione: (1994)

Loss of heterozygosity at APC and beta-catenin expression in sporadic colorectal carcinogenesis
di: Hao, X, et al.
Pubblicazione: (1998)

Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
di: Hao, X, et al.
Pubblicazione: (2002)

Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours.
di: Hao, X, et al.
Pubblicazione: (1997)

Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines.
di: El-Bahrawy, M, et al.
Pubblicazione: (2004)

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
di: Mann, B, et al.
Pubblicazione: (1999)

E-cadherin mutations in human colorectal cancer cell lines
di: Wheeler, J, et al.
Pubblicazione: (1999)

E-cadherin mutations in human colorectal cancer cell lines
di: Wheeler, J, et al.
Pubblicazione: (1999)

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
di: Ilyas, M, et al.
Pubblicazione: (1997)

Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.
di: Homfray, T, et al.
Pubblicazione: (1998)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
di: Rowan, A, et al.
Pubblicazione: (2000)

APC mutations are sufficient for the growth of early colorectal adenomas.
di: Lamlum, H, et al.
Pubblicazione: (2000)

Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
di: Johnson, V, et al.
Pubblicazione: (2005)

Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.
di: Efstathiou, J, et al.
Pubblicazione: (1998)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
di: Beck, N, et al.
Pubblicazione: (1997)

Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
di: Hao, X, et al.
Pubblicazione: (1997)

Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
di: Ilyas, M, et al.
Pubblicazione: (1999)

TP53 and Beta-catenin mutations in liver tumours
di: Pierre Hainaut
Pubblicazione: (2007-02-01)

Genetic pathways in colorectal and other cancers.
di: Ilyas, M, et al.
Pubblicazione: (1999)

Genetic pathways in colorectal and other cancers.
di: Ilyas, M, et al.
Pubblicazione: (1999)

Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy.
di: Browning, M, et al.
Pubblicazione: (1993)

Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice.
di: Wilding, J, et al.
Pubblicazione: (2002)

Diagnostic Utility of Beta-Catenin in Poorly Differentiated Colorectal Carcinoma
di: Farukh Mir Muhammad, et al.
Pubblicazione: (2023-12-01)

The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma
di: Guilherme Muniz Bourroul, et al.

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
di: Bicknell, D, et al.
Pubblicazione: (1996)

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
di: Liu, Y, et al.
Pubblicazione: (2006)

The majority of β-catenin mutations in colorectal cancer is homozygous
di: Alexander Arnold, et al.
Pubblicazione: (2020-10-01)

Nuclear beta-catenin expression and Wnt signalling: in defence of the dogma.
di: Fodde, R, et al.
Pubblicazione: (2010)

ABNORMALITIES IN HLA EXPRESSION ON COLORECTAL TUMOR-CELL LINES - IMPLICATIONS FOR ANTIGEN PRESENTATION
di: Browning, M, et al.
Pubblicazione: (1993)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas
di: Douglas, E, et al.
Pubblicazione: (2004)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas.
di: Douglas, E, et al.
Pubblicazione: (2004)

Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
di: Tomlinson, I, et al.
Pubblicazione: (1996)

Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
di: He K, et al.
Pubblicazione: (2023-05-01)

Subcellular Localization of Beta Catenin in Colorectal Non Neoplastic and Neoplastic Lesions
di: Diah Rini Handjari, et al.
Pubblicazione: (2012-01-01)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
di: Bicknell, D, et al.
Pubblicazione: (2001)

A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
di: Bicknell, D, et al.
Pubblicazione: (2005)

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
di: Halford, SE, et al.
Pubblicazione: (2003)

Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors.
di: Maretto, S, et al.
Pubblicazione: (2003)

Mutations in Bcl10 are very rare in colorectal cancer.
di: Stone, J, et al.
Pubblicazione: (1999)